• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.07 -0.16
(-0.17%)
EUR-INR
109.74 0.07
(0.06%)
GBP-INR
127.99 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
66.2307167
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
64.08
4048.4
EPS(TTM)
Face Value()
Div & Yield %
6.3
1
0.02
 

Atishay secures AI deal with Myanmar-based tech company
Jul 20,2026

Atishay  has executed a software development agreement with Global Top Link Technologies Company , Myanmar for the design, development, and deployment of an AI-Powered Centralized Diagnostic Platform, Phase I.

The total consideration of the contract is USD 295,740 towards Phase I development, and USD 80,000 per annum towards maintenance and support (exclusive of all applicable duties and taxes).

This milestone represents the company's first international work order in the AI Diagnostic domain and underscores the growing global recognition of its technological capabilities and execution excellence.